Connor, Clark & Lunn Investment Management (CC&L)’s Amicus Therapeutics FOLD Stock Holding History

Quarter Market Value Status Shares Shares
Change %
Trade Value Portfolio Weight Portfolio Position
2025
Q2
$10.5M Buy
1,839,249
+1,053,015
+134% +$6.03M 0.04% 386
2025
Q1
$6.42M Buy
786,234
+483,698
+160% +$3.95M 0.03% 433
2024
Q4
$2.85M Buy
302,536
+79,602
+36% +$750K 0.01% 634
2024
Q3
$2.38M Buy
222,934
+75,807
+52% +$810K 0.01% 625
2024
Q2
$1.46M Buy
+147,127
New +$1.46M 0.01% 749
2024
Q1
Sell
-110,665
Closed -$1.57M 1581
2023
Q4
$1.57M Buy
110,665
+46,136
+71% +$655K 0.01% 728
2023
Q3
$785K Buy
64,529
+11,578
+22% +$141K ﹤0.01% 898
2023
Q2
$665K Buy
52,951
+18,173
+52% +$228K ﹤0.01% 913
2023
Q1
$386K Buy
+34,778
New +$386K ﹤0.01% 954
2022
Q3
Sell
-110,652
Closed -$1.19M 1156
2022
Q2
$1.19M Buy
+110,652
New +$1.19M 0.01% 582
2021
Q1
Sell
-107,942
Closed -$2.49M 1010
2020
Q4
$2.49M Buy
+107,942
New +$2.49M 0.01% 463
2018
Q2
Sell
-11,514
Closed -$173K 1057
2018
Q1
$173K Sell
11,514
-144,812
-93% -$2.18M ﹤0.01% 664
2017
Q4
$2.25M Sell
156,326
-270,263
-63% -$3.89M 0.01% 408
2017
Q3
$6.43M Buy
426,589
+404,839
+1,861% +$6.11M 0.04% 259
2017
Q2
$219K Buy
+21,750
New +$219K ﹤0.01% 726
2016
Q1
Sell
-129,434
Closed -$1.26M 857
2015
Q4
$1.26M Sell
129,434
-253,525
-66% -$2.46M 0.01% 411
2015
Q3
$5.36M Sell
382,959
-308,975
-45% -$4.32M 0.04% 194
2015
Q2
$9.79M Sell
691,934
-144,675
-17% -$2.05M 0.09% 110
2015
Q1
$9.1M Buy
836,609
+310,700
+59% +$3.38M 0.08% 118
2014
Q4
$4.38M Buy
525,909
+389,309
+285% +$3.24M 0.04% 168
2014
Q3
$813K Buy
+136,600
New +$813K 0.01% 333
2014
Q2
Sell
-14,624
Closed -$33K 567
2014
Q1
$33K Sell
14,624
-13,176
-47% -$29.7K ﹤0.01% 665
2013
Q4
$69K Buy
27,800
+8,700
+46% +$21.6K ﹤0.01% 709
2013
Q3
$46K Buy
+19,100
New +$46K ﹤0.01% 507